VU-71
VU-71 je agonist glutamatnog receptora.[3][4]
![N-[2,4-di(fenil)pirazol-3-il]-4-nitrobenzamid](/wiki/%D0%94%D0%B0%D1%82%D0%BE%D1%82%D0%B5%D0%BA%D0%B0:VU-71.png)
| |
| Nazivi | |
|---|---|
| IUPAC naziv
N-[2,4-di(fenil)pirazol-3-il]-4-nitrobenzamid
| |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C22H16N4O3 | |
| Molarna masa | 384,40 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Reference уреди
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Kamondanai Hemstapat; Tomas de Paulis; Yelin Chen; Ashley E Brady; Vandana K Grover; David Alagille; Gilles D Tamagnan; P Jeffrey Conn (2006). „A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators”. Mol Pharmacol. 70 (2): 616—26. doi:10.1124/mol.105.021857.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.
